| Literature DB >> 23690804 |
Shu-rong Lu1, Jian Su, Quan-yong Xiang, Feng-yun Zhang, Ming Wu.
Abstract
To investigate the prevalence of active transport (AT, defined as walking or bicycling for transport) and to explore the association between AT and health outcomes, we conducted a population-based cross-sectional study in Jiangsu, China, where walking and bicycling are still the main modes of transport. In this study, 8400 community residents aged 18 or above were interviewed following a multistage random sampling method (100% response rate). Face-to-face questionnaire survey data, anthropometric measurements, and biochemical data from blood tests were collected. Results show that 49.6% of the subjects, as part of daily transport, actively traveled on average 5.3 days per week, 53.5 minutes per day, and 300.3 minutes per week. There was an inverse correlation between AT and some health outcomes: AT respondents had a higher prevalence of cholesterol disorder; AT respondents who actively travelled every day had a higher risk of diabetes, whilst AT respondents with shorter daily or weekly duration had a lower risk of obesity, central obesity, and cholesterol disorder. Moreover, AT influences more health aspects among urban residents than among rural residents. Findings of this study do not support the notion that AT is beneficial to population health. Further research is needed in determining the negative side effects of AT.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23690804 PMCID: PMC3649642 DOI: 10.1155/2013/624194
Source DB: PubMed Journal: J Environ Public Health ISSN: 1687-9805
Figure 1Sample assignment and sampling methods.
Characteristics of study participants (%).
| AT | Non-AT | Total | |
|---|---|---|---|
| Gender* | |||
| Male | 41.72 | 48.82 | 45.30 |
| Female | 58.28 | 51.18 | 54.70 |
| Residence | |||
| Urban | 35.45 | 35.97 | 35.71 |
| Rural | 64.55 | 64.03 | 64.29 |
| Age* | |||
| 18–34 | 10.01 | 14.10 | 12.07 |
| 35–44 | 17.28 | 23.64 | 20.49 |
| 45–54 | 22.18 | 23.59 | 22.89 |
| 55–64 | 27.72 | 20.55 | 24.11 |
| ~65 | 22.80 | 18.12 | 20.44 |
| Educational level* | |||
| Low | 51.15 | 44.71 | 47.90 |
| Medium | 42.22 | 49.50 | 45.89 |
| High | 6.63 | 5.79 | 6.20 |
| Household income level* | |||
| Low | 41.67 | 35.16 | 38.42 |
| Medium | 32.82 | 34.84 | 33.83 |
| High | 25.51 | 30.01 | 27.75 |
| Overall physical activity level* | |||
| Inactive | 7.42 | 21.15 | 13.28 |
| Moderate | 34.66 | 33.07 | 33.98 |
| Active | 57.92 | 45.78 | 52.74 |
*P < 0.01.
Health indices/outcomes differences between AT and non-AT respondents.
| AT respondents | Non-AT respondents | |||||
|---|---|---|---|---|---|---|
| Prevalence | 95% CI | Prevalence | 95% CI | |||
| /mean | Lower | Upper | /mean | Lower | Upper | |
| Obesity (%) | 13.88 | 12.83 | 14.93 | 13.40 | 12.38 | 14.43 |
| Central obesity (%)** | 42.95 | 41.44 | 44.45 | 40.79 | 39.31 | 42.27 |
| Hypertension (%)* | 50.97 | 49.45 | 52.49 | 47.34 | 45.84 | 48.85 |
| Diabetes (%) | 8.76 | 7.90 | 9.62 | 8.22 | 7.39 | 9.05 |
| Cholesterol disorder (%)* | 34.36 | 32.92 | 35.80 | 29.69 | 28.32 | 31.07 |
| BMI (cm) | 24.35 | 24.24 | 24.45 | 24.35 | 24.24 | 24.45 |
| WC (cm)* | 82.50 | 82.21 | 82.79 | 82.44 | 82.15 | 82.74 |
| SBP (mmHg)* | 139.21 | 138.53 | 139.88 | 137.66 | 136.98 | 138.34 |
| DBP (mmHg) | 84.83 | 84.49 | 85.18 | 84.92 | 84.58 | 85.27 |
| FBG (mmol/L) | 5.63 | 5.59 | 5.67 | 5.57 | 5.53 | 5.62 |
| TC (mmol/L)* | 4.37 | 4.33 | 4.40 | 4.49 | 4.46 | 4.52 |
| HDL-C (mmol/L)* | 1.32 | 1.31 | 1.33 | 1.38 | 1.36 | 1.39 |
| LDL-C (mmol/L) | 2.27 | 2.25 | 2.29 | 2.28 | 2.26 | 2.31 |
| TG (mmol/L) | 1.53 | 1.48 | 1.57 | 1.49 | 1.45 | 1.53 |
*P < 0.01;**P < 0.05.
Health outcomes/indices and frequency and duration of AT.
| Frequency (days/week) | Daily duration (minutes/day) | |||||
|---|---|---|---|---|---|---|
| 1-2 | 3–6 | 7 | <30 | 30–60 | >60 | |
| Obesity (%) | 13.63 | 12.85 | 14.58 | 10.70 | 14.53 | 15.12 |
| Central obesity (%) | 41.43 | 41.08 | 44.50 | 41.09 | 42.32 | 44.68 |
| Hypertension (%)∗† | 48.02 | 48.99 | 53.02 | 45.81 | 50.19 | 54.84 |
| Diabetes (%) | 7.61 | 7.21 | 10.03 | 7.34 | 9.50 | 8.86 |
| Cholesterol disorder (%)† | 31.38 | 33.81 | 35.55 | 29.66 | 35.01 | 36.50 |
| BMI (cm) | 24.11 | 24.31 | 24.44 | 24.06 | 24.43 | 24.44 |
| WC (cm)* | 81.96 | 82.07 | 82.92 | 81.67 | 82.59 | 82.91 |
| SBP (mmHg)† | 138.97 | 138.78 | 139.53 | 135.70 | 139.86 | 140.64 |
| DBP (mmHg) | 84.42 | 84.78 | 84.98 | 83.87 | 85.35 | 84.89 |
| FBG (mmol/L) | 5.55 | 5.53 | 5.72 | 5.60 | 5.62 | 5.66 |
| TC (mmol/L)* | 4.38 | 4.36 | 4.37 | 4.39 | 4.40 | 4.32 |
| HDL-C (mmol/L)† | 1.35 | 1.32 | 1.31 | 1.35 | 1.31 | 1.31 |
| LDL-C (mmol/L) | 2.22 | 2.25 | 2.30 | 2.26 | 2.30 | 2.25 |
| TG (mmol/L) | 1.44 | 1.42 | 1.61 | 1.48 | 1.55 | 1.53 |
*P < 0.05 between different groups of frequency; † P < 0.05 between different groups of daily duration.
Logistic regression results with AT and prevalence of health outcomes.
| Category | OR | 95% CI | ||
|---|---|---|---|---|
| Lower | Upper | |||
| Obesity | ||||
| AT or Non-AT | 1.04 | 0.90 | 1.21 | |
| Frequency (days/week)$ | 1-2 | 0.98 | 0.73 | 1.30 |
| 3–6 | 0.88 | 0.71 | 1.10 | |
| 7 | ||||
| Daily duration (minutes/day)# | <30* | 0.63 | 0.48 | 0.83 |
| 30–60 | 0.92 | 0.75 | 1.14 | |
| >60 | ||||
|
| ||||
| Central obesity | ||||
| AT or Non-AT | 0.98 | 0.88 | 1.09 | |
| Frequency (days/week) | 1-2* | 0.81 | 0.66 | 1.00 |
| 3–6 | 0.87 | 0.74 | 1.01 | |
| 7 | ||||
| Daily duration (minutes/day) | <30* | 0.82 | 0.68 | 0.99 |
| 30–60 | 0.91 | 0.78 | 1.06 | |
| >60 | ||||
|
| ||||
| Hypertension | ||||
| AT or Non-AT | 0.98 | 0.88 | 1.10 | |
| Frequency (days/week) | 1-2 | 0.86 | 0.70 | 1.07 |
| 3–6 | 0.91 | 0.78 | 1.07 | |
| 7 | ||||
| Daily duration (minutes/day) | <30 | 0.87 | 0.72 | 1.06 |
| 30–60 | 0.93 | 0.79 | 1.10 | |
| >60 | ||||
|
| ||||
| Diabetes | ||||
| AT or Non-AT | 1.04 | 0.86 | 1.25 | |
| Frequency (days/week) | 1-2 | 0.72 | 0.50 | 1.04 |
| 3–6* | 0.70 | 0.53 | 0.92 | |
| 7 | ||||
| Daily duration (minutes/day) | <30 | 0.93 | 0.67 | 1.30 |
| 30–60 | 1.11 | 0.85 | 1.45 | |
| >60 | ||||
|
| ||||
| Cholesterol disorder | ||||
| AT or Non-AT | 1.26 | 1.13 | 1.41 | |
| Frequency (days/week) | 1-2 | 0.81 | 0.66 | 1.00 |
| 3–6 | 0.91 | 0.78 | 1.06 | |
| 7 | ||||
| Daily duration (minutes/day) | <30* | 0.68 | 0.56 | 0.82 |
| 30–60 | 0.91 | 0.78 | 1.06 | |
| >60 | ||||
(1) All adjusted by age, gender, educational level, household income level, and overall physical activity level.
(2) Probability for entry 0.05, for removal 0.10.
(3) 0 for non-AT or nodisease, 1 for AT or disease.
(4) $Taking “7 days/week” as control; #taking “>60 min/day” as control.
(5) *P < 0.05.
Logistic regression results with AT weekly duration and health outcomes.
| Weekly duration (minutes/week)$ | OR | 95% CI | |
|---|---|---|---|
| Lower | Upper | ||
| Obesity | |||
| <105* | 0.72 | 0.54 | 0.95 |
| 105–420* | 0.79 | 0.63 | 0.99 |
| >420 | |||
| Central obesity | |||
| <105* | 0.76 | 0.62 | 0.94 |
| 105–420 | 0.85 | 0.72 | 1 |
| >420 | |||
| Hypertension | |||
| <105 | 0.83 | 0.68 | 1.03 |
| 105–420 | 0.87 | 0.73 | 1.03 |
| >420 | |||
| Diabetes | |||
| <105 | 0.75 | 0.53 | 1.06 |
| 105–420 | 0.9 | 0.69 | 1.19 |
| >420 | |||
| Cholesterol disorder | |||
| <105* | 0.64 | 0.52 | 0.79 |
| 105–420 | 0.86 | 0.73 | 1.01 |
| >420 | |||
(1) All adjusted by age, gender, educational level, household income level, and overall physical activity level.
(2) Probability for entry 0.05, for removal 0.10.
(3) 0 for non-AT or nodisease, 1 for AT or disease.
(4) $Taking “>420” as control.
(5) *P < 0.05.